Table of Content




1. Executive Summary


2. Global Oncology Molecular Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Oncology Molecular Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Oncology Molecular Diagnostic Market by Product Type
3.3.1: Instruments
3.3.2: Reagents
3.3.3: Others

3.4: Global Oncology Molecular Diagnostic Market by Type
3.4.1: Blood Cancer
3.4.2: Breast Cancer
3.4.3: Prostate Cancer
3.4.4: Colorectal Cancer
3.4.5: Liver Cancer
3.4.6: Lung Cancer
3.4.7: Skin Cancer
3.4.8: Cervical Cancer
3.4.9: Others

3.5: Global Oncology Molecular Diagnostic Market by Technology
3.5.1: Polymerase Chain Reaction (PCR)
3.5.2: In-situ Hybridization (ISH)
3.5.3: Isothermic Nucleic Acid Amplification Technology (INNAT)
3.5.4: Chips & Microarrays
3.5.5: Sequencing
3.5.6: Mass Spectroscopy
3.5.7: Transcription Mediated Amplification (TMA)
3.5.8: Others

3.6: Global Oncology Molecular Diagnostic Market by End Use
3.6.1: Hospitals and Diagnostic Centers
3.6.2: Reference Laboratories
3.6.3: Pharmaceutical and Biotechnology
3.6.4: Academic & Research Institutes
3.6.5: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Oncology Molecular Diagnostic Market by Region
4.2: North American Oncology Molecular Diagnostic Market
4.2.1: North American Oncology Molecular Diagnostic Market by Type: Blood Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Skin Cancer, Cervical Cancer, and Others

4.2.2: North American Oncology Molecular Diagnostic Market by End Use: Hospitals and Diagnostic Centers, Reference Laboratories, Pharmaceutical and Biotechnology, Academic & Research Institutes, and Others

4.3: European Oncology Molecular Diagnostic Market

4.3.1: European Oncology Molecular Diagnostic Market by Type: Blood Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Skin Cancer, Cervical Cancer, and Others

4.3.2: European Oncology Molecular Diagnostic Market by End Use: Hospitals and Diagnostic Centers, Reference Laboratories, Pharmaceutical and Biotechnology, Academic & Research Institutes, and Others

4.4: APAC Oncology Molecular Diagnostic Market

4.4.1: APAC Oncology Molecular Diagnostic Market by Type: Blood Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Skin Cancer, Cervical Cancer, and Others

4.4.2: APAC Oncology Molecular Diagnostic Market by End Use: Hospitals and Diagnostic Centers, Reference Laboratories, Pharmaceutical and Biotechnology, Academic & Research Institutes, and Others

4.5: ROW Oncology Molecular Diagnostic Market

4.5.1: ROW Oncology Molecular Diagnostic Market by Type: Blood Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Skin Cancer, Cervical Cancer, and Others

4.5.2: ROW Oncology Molecular Diagnostic Market by End Use: Hospitals and Diagnostic Centers, Reference Laboratories, Pharmaceutical and Biotechnology, Academic & Research Institutes, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Oncology Molecular Diagnostic Market by Product Type
6.1.2: Growth Opportunities for the Global Oncology Molecular Diagnostic Market by Type
6.1.3: Growth Opportunities for the Global Oncology Molecular Diagnostic Market by Technology
6.1.4: Growth Opportunities for the Global Oncology Molecular Diagnostic Market by End Use
6.1.5: Growth Opportunities for the Global Oncology Molecular Diagnostic Market by Region

6.2: Emerging Trends in the Global Oncology Molecular Diagnostic Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Oncology Molecular Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oncology Molecular Diagnostic Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Abbott
7.2: Becton
7.3: Dickinson
7.4: F. Hoffmann-La Roche
7.5: Cepheid
7.6: Bayer
7.7: Agilent Technologies
7.8: Danaher
7.9: Hologic
7.10: Sysmex